Raymond v. Boehringer Ingelheim Pharmaceuticals, Inc.

653 F. Supp. 2d 151, 2009 U.S. Dist. LEXIS 76578, 107 Fair Empl. Prac. Cas. (BNA) 338, 2009 WL 2840909
CourtDistrict Court, D. Connecticut
DecidedAugust 27, 2009
DocketCivil Action 3:06-cv-1362
StatusPublished

This text of 653 F. Supp. 2d 151 (Raymond v. Boehringer Ingelheim Pharmaceuticals, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Connecticut primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Raymond v. Boehringer Ingelheim Pharmaceuticals, Inc., 653 F. Supp. 2d 151, 2009 U.S. Dist. LEXIS 76578, 107 Fair Empl. Prac. Cas. (BNA) 338, 2009 WL 2840909 (D. Conn. 2009).

Opinion

MEMORANDUM OF DECISION AND ORDER

VANESSA L. BRYANT, District Judge.

This case was tried to the court from January 7, 2009 until January 12, 2009. The plaintiff, Dr. Robert Raymond, brought this action against the defendant, Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) alleging violations of the Age Discrimination in Employment Act, 29 U.S.C. § 621 et seq. (“ADEA”) and Connecticut Fair Employment Practices Act (“CFEPA”) Conn. Gen.Stat. § 46a-60 et seq. For the reasons hereinafter stated, the Court finds that BIPI has not proven that for the year prior to his termination, Raymond was a bona-fide executive or high policy maker, the exception to discriminatory termination under the ADEA. Accordingly, judgment is hereby entered for the plaintiff.

Facts

The Court finds the following facts. Raymond was born on October 29, 1939. He is a lawyer with a Ph.D. in organic chemistry who practiced intellectual property law, concentrating on pharmaceutical patents. BIPI terminated Raymond on October 31, 2004. BIPI is a pharmaceutical company with a center of operations in Ridgefield, Connecticut, and is one of several subsidiaries of a German parent company. The management of BIPI and its sibling companies is centralized in Germany. BIPI hired Raymond as its chief patent counsel, effective October 31,1994, two days after his fifty-fifth birthday.

As BIPI’s chief patent counsel, Raymond originally oversaw BIPI’s entire patent law group and reported directly to BIPI’s general counsel, Ursula Bartels. The patent law group took the lead on securing patents for BIPI inventions and directing legal initiatives to protect those patents from infringement. Raymond advised other affiliates of BIPI’s German parent on patent law. He directed and collaborated with outside counsel on patent matters, though there was no evidence that he had any role in retaining outside counsel. BIPI had a management committee that made policy decisions affecting BIPI specifically. Raymond attended meetings of this committee only twice, each time at Bartels’ request. In around 2000, Raymond began reporting informally to the German parent’s patent head.

On October 1, 2002, the month of his sixty-third birthday, BIPI promoted Raymond to Vice President Intellectual Property. The promotion did not increase *154 Raymond’s duties or responsibilities. The promotion proposal submitted to the German parent’s board of directors for approval stated that the chief patent counsel’s workload had increased significantly in recent years, and the title of vice president would be commensurate with the position’s duties and necessary for BIPI’s succession plans. According to the proposal, “it is expected that Dr. Raymond would hold this title until his retirement in two years time. Prior to that time, our succession plan calls for recruitment of an external candidate for this position. Preliminary research indicates that, to be competitive, a vice president title will be required.” [Doc. # 40, Ex. 3]

In early 2003, Raymond was asked to assist BIPI’s search for his potential successor as vice president and chief patent counsel. On August 29, 2003, BIPI hired Michael Morris as an attorney in the patent group. Morris gradually usurped Raymond’s professional and managerial duties; Raymond’s direct reports began reporting to Morris. By December 2003, Morris no longer reported to Raymond but directly to Bartels. In an April 12, 2004, email, Bartels referred to Morris as the “de facto head of the department.” [Doc. # 40, Ex. 6] The evidence introduced at trial showed that Raymond effectively ceased to manage other lawyers during 2004. Morris made all hiring decisions in 2004.

In 2004, Raymond’s area of focus was patent litigation for BIPI and related companies. The details of Raymond’s involvement in the litigation remain murky; however, he spent the majority of his time monitoring, consulting on, and attending a trial in which a BIPI sibling company was the plaintiff. He entered an appearance pro hoc vice in one case, an unusual step for a patent prosecutor, but there was no testimony elicited that would show that Raymond was making major strategic decisions in the case, such as whether or for what amount to settle the case.

In September 22, 2004, Raymond met with David Nurnberger, vice president human resources, to discuss his retirement. At that meeting, Nurnberger informed Raymond that BIPI had a mandatory retirement policy for executives upon reaching the age of sixty-five.

Following the meeting, Raymond told Nurnberger that he believed that the company’s age based retirement policy was illegal and provided copies of a court decision analyzing what Raymond believes to be a similar mandatory retirement policy for executives, Whittlesey v. Union Carbide Corp., 567 F.Supp. 1320 (S.D.N.Y. 1983). He checked BIPI’s policy database and found no mandatory retirement policy, because the mandatory retirement policy had not yet been published at the time. On September 28, 2004, despite Raymond’s objections based on the Whittlesey case, Nurnberger sent Raymond a letter confirming that as his sixty fifth birthday occurred in October 2004, Raymond’s retirement would become effective October 31, 2004. [Doc. #34-1, Ex. 4] Raymond continued his objection to the mandatory retirement policy throughout October 2004. On October 29, 2004, Raymond turned sixty-five. On October 31, 2004, he complied with BIPI’s policy, retired, and began collecting pension benefits. On November 1, 2004, Morris succeeded Raymond as vice president intellectual property and chief patent counsel.

After this termination, Raymond spoke to one headhunter in search of employment. He attended two patent law events at which he passed out business cards promoting himself as a potential consultant or expert, and sent his resume to about a dozen major law firms with large intellectual property departments. As a result of his termination, his income declined preci *155 pitously in the year after termination. Eventually, Raymond increased his income by working as an expert witness.

On August 31, 2006, Raymond initiated this lawsuit by filing a complaint claiming that BIPI’s enforcement of its mandatory retirement policy: 1) violated the ADEA; 2) constituted a willful violation of the ADEA; 3) breached Raymond’s employment contract; and 4) violated CFEPA. [Doc. # 1] On December 27, 2007, BIPI moved for summary judgment on all counts. [Doc. # 31] On December 31, 2007, Raymond filed a cross-motion for summary judgment on all counts. [Doc. 37] On August 21, 2008, the Court denied Raymond’s motion for summary judgment and granted BIPI’s motion for summary judgment as to counts 2 and 3 of his complaint and denied it in all other respects. Raymond v. Boehringer Ingelheim Pharmaceuticals, Inc., 578 F.Supp.2d 391 (D.Conn.2008). In their joint trial memorandum, the parties stipulated that the sole contested issue of law and fact for trial was “whether Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Trans World Airlines, Inc. v. Thurston
469 U.S. 111 (Supreme Court, 1985)
Morrissey v. Boston Five Cents Savings Bank FSB
866 F. Supp. 643 (D. Massachusetts, 1994)
Whittlesey v. Union Carbide Corp.
567 F. Supp. 1320 (S.D. New York, 1983)
Serricchio v. Wachovia Securities, LLC
606 F. Supp. 2d 256 (D. Connecticut, 2009)
Raymond v. Boehringer Ingelheim Pharmaceuticals, Inc.
578 F. Supp. 2d 391 (D. Connecticut, 2008)
Kiser v. Naperville Community Unit
227 F. Supp. 2d 954 (N.D. Illinois, 2002)
Sands v. Runyon
28 F.3d 1323 (Second Circuit, 1994)

Cite This Page — Counsel Stack

Bluebook (online)
653 F. Supp. 2d 151, 2009 U.S. Dist. LEXIS 76578, 107 Fair Empl. Prac. Cas. (BNA) 338, 2009 WL 2840909, Counsel Stack Legal Research, https://law.counselstack.com/opinion/raymond-v-boehringer-ingelheim-pharmaceuticals-inc-ctd-2009.